The age- and amyloid-β-related increases in Nogo B contribute to microglial activation

Neurochemistry International

Volumn 58, Issue 2, 2011, Pages 161-168

  Murphy, Kevin J ^a   Miller, Anne Marie ^a   Thelma, R ^a   Cowley, F ^a   Fionnuala Cox, F ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Age; Amyloid ; Caspase; Hippocampus; Long term potentiation; Microglial activation; Neuroinflammation; Nogo; Synaptic deterioration

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; CASPASE 8; CELL MARKER; PROTEIN NOGO; PROTEIN NOGO A; PROTEIN NOGO B; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL STRESS; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; MICROGLIA; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; GLIOSIS; HIPPOCAMPUS; INFLAMMATION; MALE; MICROGLIA; MYELIN PROTEINS; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 78651228975     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.11.009     Document Type: Article

References (50)

1. L. Acevedo, J. Yu, H. Erdjument-Bromage, R.Q. Miao, J.E. Kim, D. Fulton, P. Tempst, S.M. Strittmatter, and W.C. Sessa A new role for Nogo as a regulator of vascular remodeling Nat. Med. 10 2004 382 388
2. K.D. Beck, H.X. Nguyen, M.D. Galvan, D.L. Salazar, T.M. Woodruff, and A.J. Anderson Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment Brain 2010
3. S.N. Burke, and C.A. Barnes Neural plasticity in the ageing brain Nat. Rev. Neurosci. 7 2006 30 40
4. M.S. Chen, A.B. Huber, M.E. van der Haar, M. Frank, L. Schnell, A.A. Spillmann, F. Christ, and M.E. Schwab Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 Nature 403 2000 434 439
5. R.M. Clarke, A. Lyons, F. O'Connell, B.F. Deighan, C.E. Barry, N.G. Anyakoha, A. Nicolaou, and M.A. Lynch A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain J. Biol. Chem. 283 2008 1808 1817
6. R.M. Clarke, F. O'Connell, A. Lyons, and M.A. Lynch The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo Neuropharmacology 52 2007 136 145
7. S. David, E.J. Fry, and R. Lopez-Vales Novel roles for Nogo receptor in inflammation and disease Trends Neurosci. 31 2008 221 226
8. E.J. Downer, T.R. Cowley, A. Lyons, K.H. Mills, V. Berezin, E. Bock, and M.A. Lynch A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL Neurobiol. Aging 31 2010 118 128
9. S.A. Frautschy, W. Hu, P. Kim, S.A. Miller, T. Chu, M.E. Harris-White, and G.M. Cole Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology Neurobiol. Aging 22 2001 993 1005
10. P. Freund, E. Schmidlin, T. Wannier, J. Bloch, A. Mir, M.E. Schwab, and E.M. Rouiller Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates - re-examination and extension of behavioral data Eur. J. Neurosci. 29 2009 983 996
11. P. Garnier, A. Prigent-Tessier, M. Van Hoecke, N. Bertrand, C. Demougeot, O. Sordet, R.A. Swanson, C. Marie, and A. Beley Hypoxia induces caspase-9 and caspase-3 activation without neuronal death in gerbil brains Eur. J. Neurosci. 20 2004 937 946
12. T. GrandPre, F. Nakamura, T. Vartanian, and S.M. Strittmatter Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein Nature 403 2000 439 444
13. R. Griffin, R. Nally, Y. Nolan, Y. McCartney, J. Linden, and M.A. Lynch The age-related attenuation in long-term potentiation is associated with microglial activation J. Neurochem. 99 2006 1263 1272
14. A.M. Hein, M.R. Stasko, S.B. Matousek, J.J. Scott-McKean, S.F. Maier, J.A. Olschowka, A.C. Costa, and M.K. O'Banion Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice Brain Behav. Immun. 2009
15. A.B. Huber, O. Weinmann, C. Brosamle, T. Oertle, and M.E. Schwab Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions J. Neurosci. 22 2002 3553 3567
16. A. Josephson, J. Widenfalk, H.W. Widmer, L. Olson, and C. Spenger NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury Exp. Neurol. 169 2001 319 328
17. E. Kilic, A. Elali, U. Kilic, Z. Guo, M. Ugur, U. Uslu, C.L. Bassetti, M.E. Schwab, and D.M. Hermann Role of Nogo-A in neuronal survival in the reperfused ischemic brain J. Cereb. Blood Flow Metab. 2010
18. H.S. Kim, and Y.H. Suh Minocycline and neurodegenerative diseases Behav. Brain Res. 196 2009 168 179
19. 2+ depletion triggers apoptotic signals for endoplasmic reticulum (ER) overload response induced by overexpressed reticulon 3 (RTN3/HAP) J. Cell Physiol. 204 2005 549 559
20. E. Kuang, Q. Wan, X. Li, H. Xu, T. Zou, and Y. Qi ER stress triggers apoptosis induced by Nogo-B/ASY overexpression Exp. Cell Res. 312 2006 1983 1988
21. D.J. Loane, B.F. Deighan, R.M. Clarke, R.J. Griffin, A.M. Lynch, and M.A. Lynch Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain Neurobiol. Aging 30 2009 920 931
22. A.M. Lynch, D.J. Loane, A.M. Minogue, R.M. Clarke, D. Kilroy, R.E. Nally, O.J. Roche, F. O'Connell, and M.A. Lynch Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus Neurobiol. Aging 28 2007 845 855
23. G. Lynch, C.S. Rex, and C.M. Gall Synaptic plasticity in early aging Ageing Res. Rev. 5 2006 255 280
24. M.A. Lynch Long-term potentiation and memory Physiol. Rev. 84 2004 87 136
25. M.A. Lynch The multifaceted profile of activated microglia Mol. Neurobiol. 40 2009 139 156
26. M.A. Lynch Age-related neuroinflammatory changes negatively impact on neuronal function Front Aging Neurosci. 1 2010 6
27. A. Lyons, R.J. Griffin, C.E. Costelloe, R.M. Clarke, and M.A. Lynch IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro J. Neurochem. 101 2007 771 781
28. A. Lyons, A.M. Lynch, E.J. Downer, R. Hanley, J.B. O'Sullivan, A. Smith, and M.A. Lynch Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro J. Neurochem. 110 2009 1547 1556
29. N. Marklund, F.M. Bareyre, N.C. Royo, H.J. Thompson, A.K. Mir, M.S. Grady, M.E. Schwab, and T.K. McIntosh Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression J. Neurosurg. 107 2007 844 853
30. N. Marklund, D. Morales, F. Clausen, A. Hanell, O. Kiwanuka, A. Pitkanen, D.A. Gimbel, O. Philipson, L. Lannfelt, L. Hillered, S.M. Strittmatter, and T.K. McIntosh Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice Neuroscience 163 2009 540 551
31. S. Meier, A.U. Brauer, B. Heimrich, M.E. Schwab, R. Nitsch, and N.E. Savaskan Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure FASEB J. 17 2003 1153 1155
32. A.M. Miller, A. Piazza, D.S. Martin, M. Walsh, A. Mandel, A.E. Bolton, and M.A. Lynch The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025 Exp. Gerontol. 44 2009 300 304
33. A.M. Minogue, A.M. Lynch, D.J. Loane, C.E. Herron, and M.A. Lynch Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid J. Neurochem. 103 2007 914 926
34. A.H. Moore, M. Wu, S.S. Shaftel, K.A. Graham, and M.K. O'Banion Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory Neuroscience 2009
35. N.J. Morris, S.A. Ross, J.M. Neveu, W.S. Lane, and G.E. Lienhard Cloning and characterization of a 22 kDa protein from rat adipocytes: a new member of the reticulon family Biochim. Biophys. Acta 1450 1999 68 76
36. Y. Nolan, F.O. Maher, D.S. Martin, R.M. Clarke, M.T. Brady, A.E. Bolton, K.H. Mills, and M.A. Lynch Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus J. Biol. Chem. 280 2005 9354 9362
37. T. Oertle, C. Huber, H. van der Putten, and M.E. Schwab Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4 J. Mol. Biol. 325 2003 299 323
38. T. Oertle, D. Merkler, and M.E. Schwab Do cancer cells die because of Nogo-B? Oncogene 22 2003 1390 1399
39. J.H. Park, D.A. Gimbel, T. GrandPre, J.K. Lee, J.E. Kim, W. Li, D.H. Lee, and S.M. Strittmatter Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition J. Neurosci. 26 2006 1386 1395
40. A. Piazza, and M.A. Lynch Neuroinflammatory changes increase the impact of stressors on neuronal function Biochem. Soc. Trans. 37 2009 303 307
41. R. Prinjha, S.E. Moore, M. Vinson, S. Blake, R. Morrow, G. Christie, D. Michalovich, D.L. Simmons, and F.S. Walsh Inhibitor of neurite outgrowth in humans Nature 403 2000 383 384
42. F. Serrano, and E. Klann Reactive oxygen species and synaptic plasticity in the aging hippocampus Ageing Res. Rev. 3 2004 431 443
43. A.R. Simard, D. Soulet, G. Gowing, J.P. Julien, and S. Rivest Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease Neuron 49 2006 489 502
44. D.P. Stirling, K. Khodarahmi, J. Liu, L.T. McPhail, C.B. McBride, J.D. Steeves, M.S. Ramer, and W. Tetzlaff Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury J. Neurosci. 24 2004 2182 2190
45. S. Tagami, Y. Eguchi, M. Kinoshita, M. Takeda, and Y. Tsujimoto A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity Oncogene 19 2000 5736 5746
46. F.Y. Teng, B.M. Ling, and B.L. Tang Inter- and intracellular interactions of Nogo: new findings and hypothesis J. Neurochem. 89 2004 801 806
47. Q. Wang, X. Gou, L. Xiong, W. Jin, S. Chen, L. Hou, and L. Xu Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis Anesthesiology 108 2008 1071 1080
48. X. Wang, S.J. Chun, H. Treloar, T. Vartanian, C.A. Greer, and S.M. Strittmatter Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact J. Neurosci. 22 2002 5505 5515
49. R. Yan, Q. Shi, X. Hu, and X. Zhou Reticulon proteins: emerging players in neurodegenerative diseases Cell Mol. Life Sci. 63 2006 877 889
50. J. Yu, C. Fernandez-Hernando, Y. Suarez, M. Schleicher, Z. Hao, P.L. Wright, A. DiLorenzo, T.R. Kyriakides, and W.C. Sessa Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair Proc. Natl. Acad. Sci. U.S.A. 106 2009 17511 17516